By Andrew Lautz, National Taxpayers Union Last month, Senate Finance Committee Chairman Ron Wyden (D-OR) released a “Principles for Drug Pricing Reform” document that outlines how the Senator, who chairs one of the most powerful committees in Congress, would like to address prescription drug costs this year. While the document is sparse on details, […]
By Andy Blom, TES Washington Editor Joe Biden is bumbling through Europe, getting greeted (for better or worse) as “not Trump”. Benjamin Netanyahu gave his exit speech as Prime Minister of Israel and sounded more like Arnold Swarzenegger than Golda Meir (“I will be baaacckk!”). Aren’t political leaders fun? While our leaders […]
By Andy Blom, TES Washington Editor Our Vice President deals with immigration by flying over the border…but she still hasn’t visited Europe. The Senate is at a standstill, gas prices are rising and inflation is starting to show its ugly head. Welcome to summer 2021. But have hope…free market thinkers and doers […]
By Foday Turay, American Consumer Institute According to the GoodRx Research Team, 832 brand drugs have increased by an average of 4.5% since December 31, 2020. Americans pay around $1,200 for prescription drugs a year. The continuing rise of prescription drug prices has a significant impact on many Americans, especially during a global […]
By Edward Longe, American Consumer Institute The COVID-19 pandemic has, among other things, highlighted the need for global cooperation during a public health crisis. Recognizing this need, 100 developing countries, led by South Africa and India, requested the World Trade Organization (WTO) waive provisions of the Trade-Related Aspects of Intellectual Property […]
From the Geneva Network We are an informal coalition of civil society organisations that believes that continued collaboration between governments, international organisations, the private sector, and civil society is the fastest way to end the Covid-19 pandemic and kickstart stalled economic growth. Respect for intellectual property rights is key and will […]
By Grace-Marie Turner, Galen Institute The Biden administration made “the single worst presidential economic decision since Nixon’s wage-and-price controls,” The Wall Street Journal wrote in a lead editorial last week. And we agree. U.S. Trade Representative Katherine Tai said the U.S. would agree to “waive” intellectual property rights to Covid-19 vaccines and treatments and encourage other […]
By Dr. Marion Mass Congress is considering legislation to rein in runaway drug prices. But any new law would be just political theater unless it shines a light on how pharmaceutical benefit managers (PBMs) manipulate drug pricing. We soothe ourselves with slogans about America’s free-market health care. The reality is very different. […]
Creating medicine is a complex and expensive business. While U.S. biopharmaceutical companies lead the world in drug development, international trade practices can stem the flow of innovation to new markets, depriving patients in need. Limited market penetration also means fewer resources to re-invest in the most successful engine for life-saving advancements on […]
The end of January is a special time for many of us — and not always a happy one. It’s a time to realize we’ve failed to keep new year’s resolutions, to remember how much we hate cold weather, and to chafe at the U.S. healthcare system as newly reset insurance deductibles […]